Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q3 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
ELEV
Shares outstanding
62,337,402
Price per share
$0.36
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,000
Total reported value
$720
Share change
-29,532,291
Value change
-$10,839,956
Number of holders
1
Price from insider filings
$0.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 7% $1,243,200 4,440,000 BVF PARTNERS L P/IL 31 Mar 2025
TANG CAPITAL MANAGEMENT LLC 5% -50% $1,183,700 -$1,112,990 3,115,000 -48% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
VANGUARD GROUP INC 4.4% $730,813 2,610,045 The Vanguard Group 31 Dec 2024
GOLDMAN SACHS GROUP INC 2.8% $471,340 1,683,356 THE GOLDMAN SACHS GROUP, INC. 31 Dec 2024
BlackRock, Inc. 0.6% -96% $121,786 -$922,064 369,048 -88% BlackRock, Inc. 30 Jun 2025

As of 30 Sep 2025, 1 institutional investors reported holding 2,000 shares of Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV). This represents 0% of the company’s total 62,337,402 outstanding shares.

Institutional Holders of Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 2,000 $720 -$10,839,956 $0.36 1
2025 Q2 29,539,373 $10,842,562 -$793,399 $0.37 63
2025 Q1 33,845,637 $8,763,069 -$4,443,046 $0.26 70
2024 Q4 39,972,031 $22,485,726 -$3,751,358 $0.56 70
2024 Q3 45,935,957 $27,556,394 -$42,322,025 $0.60 68
2024 Q2 52,117,516 $140,354,063 +$17,123,221 $2.70 79
2024 Q1 43,980,695 $225,620,623 +$110,247,132 $5.13 61
2023 Q4 25,848,863 $13,880,951 -$1,444,457 $0.54 31
2023 Q3 28,047,314 $18,583,583 -$4,592,446 $0.66 40
2023 Q2 31,535,984 $47,935,195 +$22,145,201 $1.52 37
2023 Q1 16,211,905 $30,802,606 +$3,710,820 $1.90 26
2022 Q4 14,422,936 $13,695,323 +$98,994 $0.95 25
2022 Q3 14,278,057 $16,133,000 -$1,528,405 $1.13 20
2022 Q2 14,967,182 $20,954,000 -$7,070,388 $1.40 21
2022 Q1 18,712,066 $47,157,000 +$631,496 $2.52 27
2021 Q4 18,302,585 $110,174,000 -$3,116,564 $6.02 34
2021 Q3 15,882,998 $123,294,000 -$8,121,965 $7.79 21
2021 Q2 16,192,215 $217,245,000 +$217,245,015 $13.57 36